EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Prostate specific antigen molecular forms in breast cyst fluid and serum of women with fibrocystic breast disease



Prostate specific antigen molecular forms in breast cyst fluid and serum of women with fibrocystic breast disease



Journal of Clinical Laboratory Analysis 13(2): 75-81



We have analyzed matched serum and breast cyst fluid samples for total PSA from 148 patients with fibrocystic breast disease. We have also determined the molecular forms of PSA (free PSA and PSA bound to alpha1-antichymotrypsin) in 78 breast cyst fluid samples. We found that total PSA can be detected in all cyst fluids and in about 75% of female sera. The median total PSA concentration in breast cyst fluid (bcf) is about 30 times higher than the median in the corresponding sera. Breast cyst fluid and serum PSA are not correlated with each other. Total serum PSA is inversely associated with patient age but the inverse association between bcf PSA and age is weak. Lower total PSA in bcf was seen in women who breast feed, and higher bcf PSA is associated with multiple cysts. Type I cysts (with a high K+/ Na+ ratio) tend to have higher total PSA than Type II cysts. All but three of the fractionated cyst fluids (75/78; 96%) had free PSA as the predominant molecular form. The most consistent finding of our study was the positive association between the cyst fluid K+/Na+ ratio and the free to bound PSA ratio. This association was confirmed by Spearman correlation as well as by Wilcoxon and chi-square analysis. Secretory/apocrine cysts (Type I) tend to have more total PSA and proportionally more free PSA than transudative/flattened cysts (Type II).

(PDF emailed within 0-6 h: $19.90)

Accession: 047108134

Download citation: RISBibTeXText

PMID: 10102136

DOI: 10.1002/(sici)1098-2825(1999)13:2<75::aid-jcla6>3.0.co;2-f



Related references

Molecular forms of prostate specific antigen in serum of normal women, women with benign breast disease and women with breast cancer. Breast Cancer Research & Treatment 41(3): 231, 1996

Molecular forms of prostate-specific antigen in the serum of women with benign and malignant breast diseases. British Journal Of Cancer. 76(8): 1087-1094, 1997

Prostate specific antigen--PSA and histopathological findings of endometrium in women with fibrocystic breast disease. Ginekologia Polska 81(2): 111-114, 2010

Differential distribution of soluble and complexed forms of prostate-specific antigen in cyst fluids of women with gross cystic breast disease. Journal of Clinical Laboratory Analysis 15(2): 81-86, 2001

Differential distribution of soluble and complexed forms of prostate‐specific antigen in cyst fluids of women with gross cystic breast disease. Journal of Clinical Laboratory Analysis 15(2): 81-86, 2001

Prostate-specific antigen in breast cyst fluid: possible role of prostate-specific antigen in hormone-dependent breast cancer. International Journal of Cancer 66(6): 743-746, 1996

Super-sensitive prostate-specific antigen (PSA) in serum of women with benign breast disease or breast cancer. Anticancer Research 20(3b): 2151-2154, 2000

Fibrocystic breast disease: the significance of β-human chorionic gonadotropin and other polypeptides in breast cyst fluid. Fertility and Sterility 49(4): 638-643, 1988

Fibrocystic breast disease: the significance of beta-human chorionic gonadotropin and other polypeptides in breast cyst fluid. Fertility and Sterility 49(4): 638-643, 1988

Prostate-specific antigen in the serum of women with benign breast disease. European Journal of Obstetrics, Gynecology, and Reproductive Biology 138(2): 212-216, 2007

Prostate specific antigen: A new constituent of breast cyst fluid. Breast Cancer Research and Treatment 38(3): 259-264, 1996

Molecular heterogeneity of serum prolactin in women with fibrocystic disease and breast cancer. Journal of Gynaecological Endocrinology 2(1-2): 11-16, 1986

Prostate specific antigen in breast cyst fluid Possible role in regulation of oestrogen metabolism. Journal of Endocrinology 148(SUPPL ): RC7, 1996

Serum and breast duct fluid prolactin and estrogen levels in healthy Finnish and American women and patients with fibrocystic disease. Cancer 57(8): 1550-1554, 1986

Diagnostic value of molecular forms of prostate-specific antigen of female breast cancer. Clinical Biochemistry 29(3): 193-200, 1996